cdmo.directory
← Compare landing

Esco Aster vs Genevoyager (Wuhan) Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/escoaster/genevoyager-2

CategoryEsco AsterGenevoyager (Wuhan) Co., Ltd.
Listed sitebothboth
SummaryEsco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.
Services
  • Translational Research
  • Clinical Trial Services
  • GLP Toxicology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
Modalities
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
Indications
  • Neurology
  • Infectious Disease
  • Respiratory
  • Dermatology
Data not yet provided.
LocationsData not yet provided.
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
Certifications
  • cGMP · Identifier: cGMP-compliant
  • GLP · Identifier: GLP Toxicology
  • China · Identifier: High-tech Enterprise (高新技术企业)
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.